Business
Press Release Mar 28 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 28, 2023, titled "Zydus receives Final Approval from the USFDA for Loperamide Hydrochloride Capsules USP, 2 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 28, 2023, titled \"Zydus receives Final Approval from the USFDA for Loperamide Hydrochloride Capsules USP, 2 mg\". View Attachment","length":357,"tagName":"div"}]